Erica Blight

At the intersection of innovation and leadership stands a distinguished executive who has mastered the delicate balance between creative vision and technical excellence. This award-winning leader has consistently demonstrated the ability to transform groundbreaking technologies into multimillion-dollar market successes.

With a strategic mindset that spans the entire business spectrum, they excel at crafting comprehensive long-term business strategies that seamlessly integrate in-house development, licensing, and strategic acquisitions. Their collaborative approach has fostered powerful alignments across R&D, clinical affairs, medical affairs, reimbursement, regulatory, finance, and legal departments, effectively influencing stakeholders from entry-level positions to C-suite executives and Board members.

In the global IVD landscape, they have successfully steered businesses ranging from ambitious startups to established enterprises with revenues exceeding $600M, encompassing advanced assays, cutting-edge instruments, and sophisticated software solutions. Their visionary leadership style, coupled with a strong emphasis on accountability, has consistently driven rapid business growth and transformation.

As a compassionate leader, they have guided high-performing teams through significant organizational changes while maintaining strong employee engagement and fostering genuine followership. Their technical foundation in molecular biology, combined with hands-on laboratory management experience, provides a unique perspective that bridges scientific understanding with business acumen.

Their expertise spans an impressive array of specialties, including corporate strategy, data-driven planning, post-acquisition strategy, comprehensive marketing functions, sales management, portfolio optimization, and lifecycle management. They have demonstrated particular prowess in new product commercialization, strategic communications, KOL development, and P&L management, while excelling in team leadership, talent development, and organizational design.

Their diverse experience covers critical healthcare sectors including cancer, infectious diseases, women's health, health monitoring, immunology, and rare diseases. With extensive regional experience across APAC, EU, LATAM, and US markets, they bring a truly global perspective to the diagnostics, medical device, and life sciences industries, with particular expertise in CDx and IVD sectors.